Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up

Table 2

Baseline ophthalmological characteristics.

	Total number of patients (BCVA: n = 180, CRT: n = 56)	Treatment status
		Treatment-naïve subgroup (BCVA: n = 121, CRT: n = 48)	Previously treated subgroup (BCVA: n = 59, CRT n = 8)	value
Mean BCVA (LogMAR)	0.77 ± 0.64	0.83 ± 0.64	0.64 ± 0.60	0.0689
Mean CRT (μm)	402 ± 194	406 ± 188	378 ± 241	0.7141

Definitions: treatment-naïve eyes = no previous nAMD treatment prior to first injection at our clinic; previously treated eyes = previous nAMD treatment prior to first injection at our clinic.